Cancer Genomics & Metabolomics

Cancer Genomics & Metabolomics. Cancer genomics is a sub-field of genomics that personifies cancer-linked or cancer associated genes. Whereas Metabolomics is the quantification of small molecules formed by metabolic progressions within a biological model. Metabolomics datasets contain a wealth of information that reflect the disease state and are consequent to both genetic variation and environment.

Because cancer is a genomic disease, genomic profiling is an undeniably important tool for precision oncology. Precision Oncology alludes to the fitting of therapeutic cancer treatment to the individual qualities of every patient.

  • Cancer Metabolomics
  • Precision Oncology
  • Biomarker Metabolomics
  • Cancer immunotherapy
  • Targeted therapeutics
  • Active immunotherapies

Related Conference of Cancer Genomics & Metabolomics

October 17-18, 2019

2nd International conference on blood disorders 2019

Osaka, Japan
October 23-24, 2019

13th World Congress on Hematology and Oncology

| Tokyo, Japan
November 25-26, 2019

17th World Hematology & Blood Disorders Conference

Paris, France
March 16-17, 2020

18th World Hematology Congress

London, UK

Cancer Genomics & Metabolomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in